Are patients with pituitary adenomas at an increased risk of mental disorders?

Acta Psychiatrica Scandinavica

Volumn 107, Issue 1, 2003, Pages 60-68

  Korali, Z ^a   Wittchen, H U ^b   Pfister, H ^b   Hofler M ^b   Oefelein, W ^b   Stalla, G K ^b  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Comorbidity; Hormone deficiency; Mental disorders; Pituitary adenoma

Indexed keywords

CORTICOTROPIN; GROWTH HORMONE; PROLACTIN;

ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; HORMONE BLOOD LEVEL; HUMAN; HYPOPHYSIS ADENOMA; LIFE EVENT; MAJOR CLINICAL STUDY; MENTAL DISEASE; PRIORITY JOURNAL; PSYCHOSOCIAL ENVIRONMENT; RISK FACTOR; SYMPTOMATOLOGY;

ADENOMA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PITUITARY NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0037229337     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0447.2003.02383.x     Document Type: Article

References (36)

1. AMBROSI B, FAGLIA G. Epidemiology of pituitary tumors. Excerpta Med Int Cong Series 1991;961:159-168.
2. FISCHER PA, SCHMIDT G, WANKE K. Psychische Spätfolgen nach operativer Behandlung von Hypophysentumoren. Archiv für Psychiatric und Zeitschrift f. D Ges Neurologie 1967;210:387-406.
3. MUSSELMAN DL, NEMEROFF CB. Depression and endocrine disorders: focus on the thyroid and adrenal system. Br J Psychiatry 1996;168:123-128.
4. FAHLBUSCH R, BAROCKA A. Hormones and behavior. Acta Neurochir (Wien) 1995;132:169-177.
5. WALLYMAHMED ME, FOY P, MACFARLANE IA. The quality of life of adults with growth hormone deficiency: comparison with diabetic patients and control subjects. Clin Endocrinol 1999;51:333-338.
6. ROSÉN T, WIRÉN L, WILHELMSEN L, WIKLUND I, BENGTSSON BA. Decreased psychological well-being in adult patients with growth hormone deficiency. Clin Endocrinol 1994;40:111-116.
7. BAUM HBA, KATZNELSON L, SHERMAN JC et al. Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency. J Clin Endocrinol Metab 1998;83:3184-3189.
8. PAGE RCL, HAMMERSLEY MS, BURKE CW, WASS JAH. An account of the quality of life of patients after treatment for non-functioning pituitary tumours. Clin Endocrinol 1997;46:401-406.
9. PEACE KA, ORME SM, PRADAYATTY SJ, GODFREY HPD, BELCHETZ PE. Cognitive dysfunction in patients with pituitary tumour who have been treated with transfrontal or transsphenoidal surgery or medication. Clin Endocrinol 1998;49:391-396.
10. PEACE KA, ORME SM, THOMPSON AR, PADAYATTY S, ELLIS AW, BELCHEZ PE. Cognitive dysfuction in patients treated for pituitary tumours. J Clin Exp Neurophysiol 1997;19:1-6.
11. MCGAULEY GA. Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Paediatr Scand 1989;356:70-72.
12. FAVA GA, SONINO N, MORPHY MA. Psychosomatic view of endocrine disorders. Psychother Psychosom 1993;59: 20-33.
13. HASKETT RF. Diagnostic categorization of psychiatric disturbance in Cushing's syndrome. Am J Psychiatry 1985;142:911-916.
14. KELLY WF. Psychiatric aspects of Cushing's syndrome. QJM 1996;89:543-551.
15. KELLY WF, KELLY MJ, FARAGHER B. A prospective study of psychiatric and psychological aspects of Cushing's syndrome. Clin Endocrinol 1996;45:715-720.
16. DORN LD, BURGESS ES, FRIEDMAN TC, DUBBERT B, GOLD PW, CHROUSOS GP. The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 1997;82:912-919.
17. STARKMAN MN, SCHTEINGART DE. Neuropsychiatric manifestations of patients with Cushing's syndrome. Arch Intern Med 1981;141:215-219.
18. SONINO N, ZIELENZNY M, FAVA GA, FALLO F, BOSCARO M. Risk factors and long-term outcome in pituitary-dependent Cushing's disease. J Clin Endocrinol Metab 1996;81:2647-2652.
19. SONINO N, FAVA GA, RAFFI AR, BOSCARO M, FALLO F. Clinical correlates of major depression in Cushing's disease. Psychopathology 1998;31:302-306.
20. EZZAT S. Living with acromegaly. Endocrinol Metab Clin North Am 1992;21:753-760.
21. ABED RT, CLARK J, ELBADAWY MHF, CLIFFE MJ. Psychiatric morbidity in acromegaly. Acta Psychiatr Scand 1987;75:635-639.
22. ROCCO A, MORI F, BALDELLI R et al. Effect of chronic bromocriptine treatment on psychological profile of patients with PRL-Secreting pituitary adenomas. Psychoneuroendocrinol 1993;18:57-66.
23. SOBRINHO LG. Emotional aspects of hyperprolactinemia. Psychother Psychosom 1998;67:133-139.
24. SOBRINHO LG, ALMEIDA-COSTA JM. Hyperprolactinaemia as a result of immaturity or regression: the concept of maternal subroutine. A new model of psychoendocrine interactions. Psychother Psychosom 1992;57:128-132.
25. FAVA M, FAVA GA, KELLNER R, SERAFINI E, MASTROGIACOMO I. Psychological correaltes of hyperprolactinemia in males. Psychother Psychosom 1982;37:214-217.
26. FAVA GA. Affective disorders and endocrine disease. Psychosomatics 1994;35:341-353.
27. World Health Organization. Composite International Diagnostic Interview (CIDI). Geneva: Division of Mental Health, WHO 1990.
28. DEROGATIS LR, LIPMAN RS, COVI L. The SCL 90: an outpatient psychiatric rating scale. Psychopharmacol Bull 1973;9:13-28.
29. WITTCHEN HU, ESSAU CA, VON ZERSSEN D, KRIEG JC, ZAUDIG M. Lifetime and six-month prevalence of mental disorders in the Munich follow-up study. Eur Arch Psychiatry Clin Neurosci 1992;241:247-258.
30. WITTCHEN HU. Reliability and validity studies of the WHO Composite International Diagnostic Interview (CIDI) - a critical review. J Psychiatric Res 1994;28:57-84.
31. WITTCHEN HU, KESSLER RC, ZHAO SY, ABELSON J. Reliability and clinical validity of UM-CIDI DSM-III-R generalized anxiety disorder. J Psychiatric Res 1995;29:95-110.
32. WITTCHEN HU, ZHAO S, ABELSON JM, ABELSON JL, KESSLER RC. Reliability and procedural validity of UM-CIDI DSM-III-R phobic disorders. Psychol Med 1996;26:1169-1177.
33. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, rev. Washington, DC: American Psychiatric Association, 1987.
34. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
35. STEFANO P, PERKONNIG A, TANSELLA M, WITTCHEN HU. Prevalence and 12-month outcome of threshold and subtres-hold mental disorders in primary care. J Affect Disord 1999;56:37-48.
36. BUCKMAN MT. Psychological destress in hyperprolactinemic women. In: MACLEOD RM, THORNER MO, SCAPAGININI U eds. Prolactin basic and clinical correlates. Fidia Research Series, Vol. I. Padova: Liviana Press, 1985:601-608.